Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease

Author： Cummings Jeffrey L.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.1, 2010-01, pp. : 41-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donepezil is better tolerated than rivastigmine in mild-to-moderate Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Nicergoline in the Treatment of Mild-to-Moderate Alzheimer's Disease: A European Multicentre Trial

By Winblad B.  

Clinical Drug Investigation, Vol. 21, Iss. 9, 2001-09 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Metoprolol Tartrate in Patients with Mild-to-Moderate Essential Hypertension: A Randomised, Double-Blind, Multicentre Trial

By Koenig W.  

Clinical Drug Investigation, Vol. 21, Iss. 9, 2001-09 ,pp. : 613-619

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease: Results from a 1-Year Randomized Controlled Clinical Trial

By Rennard Stephen I.  

Drugs, Vol. 69, Iss. 5, 2009-03 ,pp. : 549-565

Adis International

Access to resources Recommend Favorite

Rivastigmine Transdermal Patch: In the Treatment of Dementia of the Alzheimer's Type

By Yang Lily P.H.   Keating Gillian M.  

CNS Drugs, Vol. 21, Iss. 11, 2007-01 ,pp. : 957-965

Adis International

Access to resources Recommend Favorite